AI - Atomwise

Revolutionizing drug discovery through advanced AI technology and massive chemical libraries at Atomwise.

Logo of Atomwise
Last Audited At

About Atomwise

Atomwise is a pioneering company in the field of artificial intelligence (AI) for drug discovery. They utilize their advanced AI engine to transform the way new medicines are developed, focusing on the most challenging problems in small molecule drug discovery. The company's mission is to create better medicines faster and more cost-effectively than traditional methods.

Atomwise's portfolio includes both wholly owned pipeline assets and co-developed projects, all backed by prominent investors. Their leading technology development and application involves a machine learning-based discovery engine that combines the power of convolutional neural networks with massive chemical libraries to discover new small molecule medicines.

Their commitment to reinventing drug discovery with AI is grounded in their team's expertise. They are dedicated to developing the best AI platform and using it to transform small molecule drug discovery.

Screenshot of Atomwise Website

More companies

Gazette

Simplifying data processing by seamlessly combining SQL, batch, and streaming paradigms with journal abstraction for efficient, unified access in popular tools and SQL engines.

Read more

Lytics

Conductor: Top-tier AI solutions & integrated offerings for business uncertainty, challenges, & optimization via our platform & Decision Engine. Trusted by industry leaders.

Read more

Preql

Simplifying business data management through user-friendly tools and community engagement with scalable, no-code solutions.

Read more

Tell us about your project

Our Hubs

London, United Kingdom

A global AI hotspot, thrives on innovation, diverse talent, and a dynamic tech ecosystem, offering unparalleled opportunities for AI engineers.

Munich, Germany

A vibrant AI hub, merges cutting-edge technology with rich cultural experiences, creating an inspiring environment for AI engineers.